{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:45:13Z","timestamp":1767998713244,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["2009-0094050"],"award-info":[{"award-number":["2009-0094050"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.clinthera.2015.04.007","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T22:05:00Z","timestamp":1430863500000},"page":"1433-1442","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of Tenofovir-based Rescue Therapy in Lamivudine-resistant Chronic Hepatitis B Patients With Failure of Lamivudine and Adefovir Combination"],"prefix":"10.1016","volume":"37","author":[{"given":"Jae Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neung Hwa","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo Ryung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Uk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Du","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Jo","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Woo","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2015.04.007_bib1","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/jhep.2001.27563","article-title":"Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy","volume":"34","author":"Yuen","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.gastro.2003.10.051","article-title":"Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B","volume":"126","author":"Peters","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2003.10.050","article-title":"Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus","volume":"126","author":"Perrillo","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/135965350701200109","article-title":"Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population","volume":"12","author":"Fung","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clinthera.2015.04.007_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.21534","article-title":"Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B","volume":"45","author":"Rapti","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib7","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/hep.20939","article-title":"Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine","volume":"42","author":"Lampertico","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s12072-010-9228-9","article-title":"Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance","volume":"5","author":"Perrillo","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clinthera.2015.04.007_bib10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1053\/j.gastro.2007.08.079","article-title":"Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients","volume":"133","author":"Lampertico","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib11","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/jmv.21898","article-title":"Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B","volume":"82","author":"Ryu","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinthera.2015.04.007_bib12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3851\/IMP2335","article-title":"Outcome of lamivudine-resistant chronic hepatitis B after up to 5 years of combination therapy with adefovir","volume":"17","author":"Seto","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clinthera.2015.04.007_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: Management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2015.04.007_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","article-title":"Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues","volume":"51","author":"van Bommel","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.21253","article-title":"Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy","volume":"44","author":"van Bommel","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/gut.2010.223206","article-title":"Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B","volume":"60","author":"Patterson","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2015.04.007_bib17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/j.gastro.2010.06.053","article-title":"Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection","volume":"139","author":"Berg","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3851\/IMP1945","article-title":"HBV DNA level at 24 weeks is the best predictor of virological response to adefovir add-on therapy in patients with lamivudine resistance","volume":"17","author":"Shin","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clinthera.2015.04.007_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/hep.24406","article-title":"Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naive patients with a partial virological response","volume":"54","author":"Zoutendijk","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2015.04.007_bib20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ajg.2011.45","article-title":"Three years of continuous entecavir therapy in treatment-naive chronic hepatitis B patients: VIRAL suppression, viral resistance, and clinical safety","volume":"106","author":"Yuen","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2015.04.007_bib21","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2012.04.037","article-title":"Long-term continuous entecavir therapy in nucleos(t)ide-naive chronic hepatitis B patients","volume":"57","author":"Ono","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2015.04.007_bib22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2893.2012.01599.x","article-title":"Prediction of response to entecavir therapy in patients with HBeAg-positive chronic hepatitis B based on on-treatment HBsAg, HBeAg and HBV DNA levels","volume":"19","author":"Shin","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinthera.2015.04.007_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jhep.2013.11.024","article-title":"Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients","volume":"60","author":"Berg","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinthera.2015.04.007_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/135965350701200309","article-title":"In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents","volume":"12","author":"Qi","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.clinthera.2015.04.007_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2893.2012.01638.x","article-title":"Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen","volume":"20","author":"Svarovskaia","year":"2013","journal-title":"J Viral Hepat"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815002313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815002313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T07:31:09Z","timestamp":1655623869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291815002313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0149291815002313"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2015.04.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}